Evidence map›Paper›PMID 38725156›Full record

ArticleBriefings in bioinformatics2024

TransPTM: a transformer-based model for non-histone acetylation site prediction.

Lingkuan Meng, Xingjian Chen, Ke Cheng, Nanjun Chen, Zetian Zheng, Fuzhou Wang, Hongyan Sun, Ka-Chun Wong

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. CLASPP: A unified model for predicting post-translational modifications.bioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lingkuan MengDepartment of Computer Science, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong.ORCID 0000-0003-0909-6849
Xingjian ChenCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, MA 02138, United States.ORCID 0000-0001-9639-1584
Ke ChengDepartment of Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong.ORCID 0000-0001-5057-3120
Nanjun ChenDepartment of Computer Science, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong.ORCID 0000-0003-1432-3495
Zetian ZhengDepartment of Computer Science, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong.ORCID 0000-0002-7199-0051
Fuzhou WangDepartment of Computer Science, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong.ORCID 0000-0002-9028-5382
Hongyan SunDepartment of Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong.ORCID 0000-0003-0932-6405
Ka-Chun WongDepartment of Computer Science, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong.ORCID 0000-0001-6062-733X

Funding

City University of Hong KongCity University of Hong Kong 2021SIRG036Innovation and Technology Commission ITB/FBL/9037/22/SNational Natural Science Foundation of China 32170654Research Grants Council of the Hong Kong Special Administrative Region CityU 11203723Shenzhen Research Institute
6 · The paper itself

Abstract

Protein acetylation is one of the extensively studied post-translational modifications (PTMs) due to its significant roles across a myriad of biological processes. Although many computational tools for acetylation site identification have been developed, there is a lack of benchmark dataset and bespoke predictors for non-histone acetylation site prediction. To address these problems, we have contributed to both dataset creation and predictor benchmark in this study. First, we construct a non-histone acetylation site benchmark dataset, namely NHAC, which includes 11 subsets according to the sequence length ranging from 11 to 61 amino acids. There are totally 886 positive samples and 4707 negative samples for each sequence length. Secondly, we propose TransPTM, a transformer-based neural network model for non-histone acetylation site predication. During the data representation phase, per-residue contextualized embeddings are extracted using ProtT5 (an existing pre-trained protein language model). This is followed by the implementation of a graph neural network framework, which consists of three TransformerConv layers for feature extraction and a multilayer perceptron module for classification. The benchmark results reflect that TransPTM has the competitive performance for non-histone acetylation site prediction over three state-of-the-art tools. It improves our comprehension on the PTM mechanism and provides a theoretical basis for developing drug targets for diseases. Moreover, the created PTM datasets fills the gap in non-histone acetylation site datasets and is beneficial to the related communities. The related source code and data utilized by TransPTM are accessible at https://www.github.com/TransPTM/TransPTM.

Indexed as

Neural Networks, ComputerProtein Processing, Post-TranslationalAcetylationAlgorithmsComputational BiologyDatabases, ProteinHumansProteinsSoftwareProteinsdeep learningNon-histone acetylationprotein language modeltransformer

Identifiers

PMID38725156
PMCPMC11082075

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.